PPT-Transcatheter Mitral

Valve Replacement with the Tendyne valve The Tendyne mitral valve system Figure 1 A The nitinol selfexpanding prosthesis has a double flame An outer flame arrow contains a cuff and an inner flame has a . Ryan Hampton. OMS IV. January 2015. Mitral Regurgitation—Indications for Valve Replacement. Considerations. Is MR severe?. Is patient symptomatic?. Is patient a good candidate?. What is Left Ventricular function?. TSXV: NVC. Alexei Marko, CEO. Chris Clark, CFO. October 2013. Forward-Looking Statements. Statements contained herein that are not based on historical or current fact, including without limitation statements containing the words “anticipates,” “believes,” “may,” “continues,” “estimates,” “expects,” and “will” and words of similar import, constitute “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. Such factors include, among others, the following: general economic and business conditions, both nationally and in the regions in which the Company operates; technology changes; competition; changes in business strategy or development plans; the ability to attract and retain qualified personnel; existing governmental regulations and changes in, or the failure to comply with, governmental regulations; liability and other claims asserted against the Company; and other factors referenced in the Company’s filings with Canadian securities regulators. Given these uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. The Company does not assume the obligation to update any forward-looking statements. . Valve Disease. Pathology . Evidence for superiority of repair. Posterior Leaflet Posterior Leaflet Posterior Leaflet. Anterior Leaflet Cusp Anterolateral Scallop (P1) Middle Scallop (P2) Commissural Scallop (P3). Structure & Function. David J McCormack . BSc(Hons) MBBS . MFSTEd. . FRCSEd. (. CTh. ) FRCS (. CTh. ) . Consultant Surgeon . . Waikato Cardiothoracic Unit . Topics to be covered…. Location of the mitral valve . Stenosis. SEQUALAE of Rheumatic fever with . carditis. MR. Commonest manifestation of RHD. Incompetence of mitral valve to close leading to backflow of blood. HEMODYNAMICS. increased volume handled by. To Treat or Not to . Treat, That . is The Question. **NAME**, DVM, DACVIM-Cardiology. **DATE**. William . Shakespeare’s . “. The . Tragedie. of Mitral. ”. To treat or not to treat: that is the question:. The Randomized MITHRAS Trial. . Philipp . Lurz. , Matthias . Unterhuber. , Karl-Philipp Rommel, Karl-. Patrik. . Kresoja. , . Tobias . Kister. , Christian Besler, Karl . Fengler. , Marcus Sandri, Ingo . Definition Mitral valve prolapse is a heart problem in which the valve that separates the upper and lower chambers of the left side of the heart does not close properly. Alternative Names Barlow sy Hakam Alzaeem, MD Consultant Cardiologist Non - invasive Lab - HMC ECHOCARDIOGRAPHY IN THE INTENSIVE CARE UNIT February 9, 2019. Overview  Introduction and Anatomy.  Chronic mitral Regurgitati with signi cant functional mitral regurgitation who are not candidates for cardiac surgery.At The Mount Sinai Hospital, we employ a variety of sophisticated imaging techniques to select patients Example. Optimization. Advantages. Limitations/Pitfalls. Vena Contracta. (VC Width). Zoom . MV . & optimize image. PLAX or Apical 3 Chamber (A3C). 2D calipers only – No calculation. Color Doppler. mohanan. K J. jr3. Anatomy of mitral valves. Funnel shaped structure with apex in left ventricle. Normal mitral orifice 4-6 sq cm. Mitral valve apparatus consists of mitral annulus, two leaflets (anterior mitral leaflet, posterior mitral leaflet) attached by about 120 . Dr . jithin. INTRODUCTION. Mitral stenosis (MS), known in the literature since at least the 1669 description by John . Mayow. , as major . manifestation of rheumatic heart disease (RHD. ),. . remains an important problem worldwide. Gregg W. Stone, MD. On behalf of Michael Mack, William Abraham, JoAnn Lindenfeld . and the COAPT Investigators. Gregg W. Stone MD. Consulting fees from . Neovasc. , Valfix, Gore. Equity/options in . Ancora.